What Researchers Did
This review article examined the history, rationale, mechanisms, and study results of oxygen therapy, including hyperbaric and normobaric oxygen, for ischemic stroke.
What They Found
While hyperbaric oxygen therapy (HBO) failed to show efficacy in three clinical trials, possibly due to delayed initiation, inadequate sample size, or excessive pressures, normobaric oxygen therapy (NBO) may also be effective if started promptly. The review suggests that oxygen therapy could still be a powerful neuroprotective strategy to extend the treatment window for acute stroke, especially if applied within the first few hours or in patients with imaging evidence of salvageable brain tissue.
What This Means for Canadian Patients
For Canadian patients experiencing an ischemic stroke, oxygen therapy is not currently a standard acute treatment, but this review highlights its potential to extend the critical time window for administering other therapies like thrombolytics. Future research into early application of oxygen therapy, guided by advanced imaging, could potentially improve outcomes by preserving brain tissue before definitive treatment.
Canadian Relevance
This review article has no direct Canadian connection, as it does not involve Canadian researchers, institutions, or patient populations.
Study Limitations
As a review article, this study's findings are limited by the quality and scope of the existing animal and human studies it synthesized, and it does not present new experimental data.